United States: Patentee's Own Clinical Trial Renders Unpatentable Patent Claims Directed To Antibody Treatment - Akin Gump Strauss Hauer & Feld LLP

In a final written decision of an inter partes review proceeding, the Patent Trial and Appeal Board found all 12 claims of a challenged patent unpatentable as either anticipated or obvious.